|
⚲
|
| Keyboard |
| Atwood Brian G
✚
|
|
|---|---|
| CIK # | 0001266567 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001266567] | |
| 4 | [0001266567] | |
| SC 13D | [0001266567] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Atwood Brian G | CERO Therapeutics Holdings Inc | [2024-10-30] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2026-01-07 | Grant | 1,612,099 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2025-05-30 | Grant | 122,549 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Pre-Funded Warrant · derivative
|
2025-03-31 | Option exercise | 294,460 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Common Stock
|
2025-03-31 | Option exercise | 294,460 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2025-03-04 | Grant | 14,936 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2025-02-24 | Grant | 254,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Pre-Funded Warrant · derivative
|
2025-02-07 | Grant | 306,120 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Warrant to Purchase Shares of Common Stock · derivative
|
2025-02-07 | Grant | 204,080 | $1.96 | 399,997 |
|
CERO Therapeutics Holdings Inc CERO
Warrant to Purchase Shares of Common Stock · derivative
|
2025-02-07 | Grant | 306,120 | $1.96 | 599,995 |
|
CERO Therapeutics Holdings Inc CERO
Pre-Funded Warrant · derivative
|
2025-02-07 | Grant | 204,080 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-12-02 | Grant | 254,000 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-09-30 | Disposed to issuer | 1,317,956 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-09-30 | Disposed to issuer | 13,857 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Series A Convertible Preferred Stock · derivative
|
2024-09-25 | Option exercise | 1,002 | $1,000.00 | 1,002,000 |
|
CERO Therapeutics Holdings Inc CERO
Common Stock
|
2024-09-25 | Option exercise | 19,358,578 | ||
|
CERO Therapeutics Holdings Inc CERO
Stock Option (Right to Buy) · derivative
|
2024-03-25 | Grant | 1,317,956 | $0.00 | |
|
CERO Therapeutics Holdings Inc CERO
Common Stock
|
2024-02-14 | Other | 125,000 | ||
|
CERO Therapeutics Holdings Inc CERO
Common Stock
|
2024-02-14 | Other | 100,527 | ||
|
CERO Therapeutics Holdings Inc CERO
Common Stock
|
2024-02-14 | Other | 148,208 | ||
|
CERO Therapeutics Holdings Inc CERO
Series A Convertible Preferred Stock · derivative
|
2024-02-14 | Grant | 1,002 | $1,000.00 | 1,002,000 |
| showing 20 of 200 most recent transactions | |||||